AEON

AEON Biopharma, Inc. Class A Common Stock (AEON)

About AEON Biopharma, Inc. Class A Common Stock (AEON)

AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.

Details

Daily high

$0.71

Daily low

$0.68

Price at open

$0.70

52 Week High

$930.96

52 Week Low

$0.40

Market cap

744,200

Dividend yield

0.00%

Volume

103,109

Avg. volume

9.1M

P/E ratio

-.04

AEON Biopharma, Inc. Class A Common Stock News